View ValuationTKG Huchems 향후 성장Future 기준 점검 0/6TKG Huchems (는) 각각 연간 2.6% 및 4.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 0.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 7.5% 로 예상됩니다.핵심 정보2.6%이익 성장률0.68%EPS 성장률Chemicals 이익 성장66.3%매출 성장률4.8%향후 자기자본이익률7.48%애널리스트 커버리지Low마지막 업데이트02 Jun 2026최근 향후 성장 업데이트Price Target Changed • Feb 23Price target decreased by 8.8% to ₩22,500Down from ₩24,667, the current price target is an average from 2 analysts. New target price is 11% above last closing price of ₩20,350. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₩1,748 for next year compared to ₩2,024 last year.Price Target Changed • Mar 27Price target decreased by 8.4% to ₩24,500Down from ₩26,750, the current price target is an average from 2 analysts. New target price is 54% above last closing price of ₩15,950. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩2,115 for next year compared to ₩2,024 last year.Price Target Changed • Jan 01Price target decreased by 8.5% to ₩26,750Down from ₩29,250, the current price target is an average from 4 analysts. New target price is 57% above last closing price of ₩17,050. Stock is down 17% over the past year. The company is forecast to post earnings per share of ₩2,062 for next year compared to ₩3,512 last year.Major Estimate Revision • Aug 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.17b to ₩1.23b. EPS estimate fell from ₩2,704 to ₩2,361 per share. Net income forecast to grow 4.9% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩28,750 unchanged from last update. Share price was steady at ₩18,940 over the past week.Major Estimate Revision • Jul 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.15b to ₩1.17b. EPS estimate fell from ₩2,716 to ₩2,356 per share. Net income forecast to shrink 19% next year vs 67% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩28,750. Share price was steady at ₩19,130 over the past week.Major Estimate Revision • Mar 06Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩1.27b to ₩1.20b. EPS estimate also fell from ₩3,173 per share to ₩2,778 per share. Net income forecast to grow 32% next year vs 52% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩31,000 unchanged from last update. Share price was steady at ₩19,760 over the past week.모든 업데이트 보기Recent updates공시 • Apr 24TKG Huchems Co., Ltd. announced that it has received KRW 50 billion in funding from J&Alpha Co., LtdOn April 23, 2026, TKG Huchems Co., Ltd. has closed the transaction.공시 • Apr 10TKG Huchems Co., Ltd. announced that it expects to receive KRW 50 billion in funding from J&Alpha Co., LtdTKG Huchems Co., Ltd. announced a private placement of series 4 unsecured privately placed exchangeable bond with bearer interest for gross proceeds of KRW 50,000,000,000 on April 8, 2026. The transaction will include participation from a new investor, J&Alpha Co., Ltd. for KRW 50,000,000,000. The bond has a maturity interest rate of 1% and will mature on April 23, 2031. The bonds are fully convertible into 2,819,283 common shares of the company at a conversion price of KRW 17,735 per share. The bonds can be converted between April 24, 2027 and March 23, 2031. The transaction is expected to close on April 23, 2026. The subscription date is April 23, 2026. The transaction has been approved by the board of directors of the company on April 8, 2026.Reported Earnings • Mar 24Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: ₩1,561 (down from ₩2,024 in FY 2024). Revenue: ₩1.13t (down 5.1% from FY 2024). Net income: ₩59.9b (down 23% from FY 2024). Profit margin: 5.3% (down from 6.5% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.8%. Earnings per share (EPS) also missed analyst estimates by 11%. Revenue is forecast to grow 9.3% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩16,900, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 14x in the Chemicals industry in South Korea. Negligible returns to shareholders over past three years.공시 • Feb 27TKG Huchems Co., Ltd., Annual General Meeting, Mar 26, 2026TKG Huchems Co., Ltd., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 173, toegye-ro, jung-gu, seoul South KoreaPrice Target Changed • Feb 23Price target decreased by 8.8% to ₩22,500Down from ₩24,667, the current price target is an average from 2 analysts. New target price is 11% above last closing price of ₩20,350. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₩1,748 for next year compared to ₩2,024 last year.Upcoming Dividend • Feb 19Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 26 February 2026. Payment date: 24 April 2026. Payout ratio is a comfortable 56% and this is well supported by cash flows. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.4%). Higher than average of industry peers (1.2%).분석 기사 • Nov 24TKG Huchems' (KRX:069260) Sluggish Earnings Might Be Just The Beginning Of Its ProblemsA lackluster earnings announcement from TKG Huchems Co., Ltd. ( KRX:069260 ) last week didn't sink the stock price. Our...New Risk • Nov 24New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.분석 기사 • May 24TKG Huchems' (KRX:069260) Sluggish Earnings Might Be Just The Beginning Of Its ProblemsThe subdued market reaction suggests that TKG Huchems Co., Ltd.'s ( KRX:069260 ) recent earnings didn't contain any...Price Target Changed • Mar 27Price target decreased by 8.4% to ₩24,500Down from ₩26,750, the current price target is an average from 2 analysts. New target price is 54% above last closing price of ₩15,950. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩2,115 for next year compared to ₩2,024 last year.New Risk • Mar 19New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.5% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.5% net profit margin).Reported Earnings • Mar 19Full year 2024 earnings: EPS in line with analyst expectations despite revenue beatFull year 2024 results: EPS: ₩2,024 (down from ₩3,512 in FY 2023). Revenue: ₩1.19t (up 13% from FY 2023). Net income: ₩77.7b (down 42% from FY 2023). Profit margin: 6.5% (down from 13% in FY 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.공시 • Feb 21TKG Huchems Co., Ltd., Annual General Meeting, Mar 21, 2025TKG Huchems Co., Ltd., Annual General Meeting, Mar 21, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 173, toegye-ro, jung-gu, seoul South KoreaPrice Target Changed • Jan 01Price target decreased by 8.5% to ₩26,750Down from ₩29,250, the current price target is an average from 4 analysts. New target price is 57% above last closing price of ₩17,050. Stock is down 17% over the past year. The company is forecast to post earnings per share of ₩2,062 for next year compared to ₩3,512 last year.Upcoming Dividend • Dec 20Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 21 April 2025. Payout ratio is a comfortable 43% but the company is paying out more than the cash it is generating. Trailing yield: 5.4%. Within top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%).분석 기사 • Nov 22TKG Huchems' (KRX:069260) Shareholders Have More To Worry About Than Only Soft EarningsA lackluster earnings announcement from TKG Huchems Co., Ltd. ( KRX:069260 ) last week didn't sink the stock price. We...공시 • Aug 28TKG Huchems Co., Ltd. (KOSE:A069260) agreed to acquire 50% stake in JL Chem Co., Ltd. for KRW 60.3 billion.TKG Huchems Co., Ltd. (KOSE:A069260) agreed to acquire 50% stake in JL Chem Co., Ltd. for KRW 60.3 billion on August 27, 2024. A cash consideration of KRW 60.33 billion will be paid by TKG Huchems for 502,721 shares. The expected completion of the transaction is August 28, 2024.Major Estimate Revision • Aug 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.17b to ₩1.23b. EPS estimate fell from ₩2,704 to ₩2,361 per share. Net income forecast to grow 4.9% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩28,750 unchanged from last update. Share price was steady at ₩18,940 over the past week.Major Estimate Revision • Jul 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.15b to ₩1.17b. EPS estimate fell from ₩2,716 to ₩2,356 per share. Net income forecast to shrink 19% next year vs 67% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩28,750. Share price was steady at ₩19,130 over the past week.New Risk • Jul 22New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 2.8% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.8% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.분석 기사 • Mar 21TKG Huchems' (KRX:069260) Solid Earnings May Rest On Weak FoundationsThe recent earnings posted by TKG Huchems Co., Ltd. ( KRX:069260 ) were solid, but the stock didn't move as much as we...Major Estimate Revision • Mar 06Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩1.27b to ₩1.20b. EPS estimate also fell from ₩3,173 per share to ₩2,778 per share. Net income forecast to grow 32% next year vs 52% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩31,000 unchanged from last update. Share price was steady at ₩19,760 over the past week.공시 • Feb 22TKG Huchems Co., Ltd., Annual General Meeting, Mar 22, 2024TKG Huchems Co., Ltd., Annual General Meeting, Mar 22, 2024, at 09:01 Korea Standard Time. Location: Namsan Square 19F, Toegyero 173, Junggu Seoul South Korea Agenda: To report Business Report, to consider audit Report; to consider Internal Accounting Control System Report; to consider approval of Financial Statements for the 22nd Term; to consider election of directors; to consider election of Executive Directors; to consider approval of ceiling amount for the remuneration onto Directors; and to consider approval of ceiling amount for the remuneration onto Auditor.Upcoming Dividend • Dec 20Upcoming dividend of ₩1,000 per share at 4.4% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 22 April 2024. Trailing yield: 4.4%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).New Risk • Oct 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Major Estimate Revision • May 25Consensus revenue estimates decrease by 10%, EPS upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from ₩1.04b to ₩939.0m. EPS estimate increased from ₩2,449 to ₩2,939 per share. Net income forecast to grow 29% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target up from ₩29,000 to ₩31,000. Share price was steady at ₩23,350 over the past week.Valuation Update With 7 Day Price Move • Mar 31Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩21,800, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 68% over the past three years.Major Estimate Revision • Jan 18Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₩1.21b to ₩1.23b. EPS estimate fell from ₩2,643 to ₩2,373 per share. Net income forecast to grow 25% next year vs 25% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩32,500 to ₩29,500. Share price was steady at ₩19,600 over the past week.Upcoming Dividend • Dec 21Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. Payout ratio is a comfortable 48% and this is well supported by cash flows. Trailing yield: 4.7%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩23,400, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 24% over the past three years.Major Estimate Revision • Jul 15Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ₩3,370 to ₩2,842 per share. Revenue forecast steady at ₩1.30b. Net income forecast to grow 46% next year vs 11% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩32,500 unchanged from last update. Share price fell 8.0% to ₩18,300 over the past week.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Upcoming Dividend • Dec 22Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 4.3%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%).Price Target Changed • Dec 10Price target increased to ₩30,750Up from ₩27,750, the current price target is an average from 4 analysts. New target price is 29% above last closing price of ₩23,750. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of ₩2,281 for next year compared to ₩1,292 last year.Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩27,450, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩31,191 per share.Major Estimate Revision • May 14Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 EPS estimate increased from ₩2,209 to ₩2,466. Revenue forecast steady at ₩772.0m. Net income forecast to grow 92% next year vs 87% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩27,750 unchanged from last update. Share price was steady at ₩21,900 over the past week.분석 기사 • May 05Is Huchems Fine Chemical (KRX:069260) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Apr 01Investors Will Want Huchems Fine Chemical's (KRX:069260) Growth In ROCE To PersistIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Reported Earnings • Mar 20Full year 2020 earnings released: EPS ₩1,292 (vs ₩1,812 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩593.5b (down 10.0% from FY 2019). Net income: ₩49.6b (down 30% from FY 2019). Profit margin: 8.4% (down from 11% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.분석 기사 • Mar 17Is Huchems Fine Chemical Corporation (KRX:069260) Popular Amongst Institutions?The big shareholder groups in Huchems Fine Chemical Corporation ( KRX:069260 ) have power over the company...Is New 90 Day High Low • Mar 10New 90-day low: ₩21,300The company is down 11% from its price of ₩23,800 on 10 December 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,740 per share.분석 기사 • Mar 02Are Huchems Fine Chemical Corporation's (KRX:069260) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?It is hard to get excited after looking at Huchems Fine Chemical's (KRX:069260) recent performance, when its stock has...공시 • Feb 27Huchems Fine Chemical Corporation, Annual General Meeting, Mar 26, 2021Huchems Fine Chemical Corporation, Annual General Meeting, Mar 26, 2021, at 09:00 Korea Standard Time.분석 기사 • Feb 15Here's What You Should Know About Huchems Fine Chemical Corporation's (KRX:069260) 4.2% Dividend YieldDividend paying stocks like Huchems Fine Chemical Corporation ( KRX:069260 ) tend to be popular with investors, and for...Major Estimate Revision • Feb 12Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate was lowered from ₩1,764 to ₩1,543. No change was made to the revenue estimate which at the last update was ₩590.1m. Net income is expected to grow by 72% next year compared to 60% growth forecast for the Chemicals industry in South Korea. The consensus price target of ₩30,000 was unchanged from the last update. Share price stayed mostly flat at ₩22,550 over the past week.Price Target Changed • Feb 03Price target raised to ₩30,000Up from ₩24,250, the current price target is an average from 2 analysts. The new target price is 28% above the current share price of ₩23,450. As of last close, the stock is up 22% over the past year.분석 기사 • Feb 01Huchems Fine Chemical (KRX:069260) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Is New 90 Day High Low • Jan 29New 90-day low: ₩21,400The company is down 7.0% from its price of ₩22,900 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 39% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,786 per share.분석 기사 • Jan 19Huchems Fine Chemical (KRX:069260) Has Compensated Shareholders With A Respectable 89% Return On Their InvestmentIf you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to...분석 기사 • Jan 06Does Huchems Fine Chemical's (KRX:069260) Statutory Profit Adequately Reflect Its Underlying Profit?As a general rule, we think profitable companies are less risky than companies that lose money. That said, the current...Price Target Changed • Dec 30Price target raised to ₩25,000Up from ₩23,250, the current price target is an average from 3 analysts. The new target price is close to the current share price of ₩25,650. As of last close, the stock is up 21% over the past year.분석 기사 • Dec 24Huchems Fine Chemical Corporation (KRX:069260) Goes Ex-Dividend SoonHuchems Fine Chemical Corporation ( KRX:069260 ) stock is about to trade ex-dividend in 3 days. You can purchase shares...Upcoming Dividend • Dec 22Upcoming Dividend of ₩1,000 Per ShareWill be paid on the 24th of April to those who are registered shareholders by the 29th of December. The trailing yield of 4.1% is in the top quartile of South Korean dividend payers (2.6%), and it is higher than industry peers (0.9%).분석 기사 • Dec 13What Is The Ownership Structure Like For Huchems Fine Chemical Corporation (KRX:069260)?A look at the shareholders of Huchems Fine Chemical Corporation ( KRX:069260 ) can tell us which group is most...분석 기사 • Nov 29Is Huchems Fine Chemical Corporation's (KRX:069260) Recent Stock Performance Influenced By Its Fundamentals In Any Way?Huchems Fine Chemical's (KRX:069260) stock is up by a considerable 36% over the past three months. Given that stock...Major Estimate Revision • Nov 12Analysts lower revenue estimates to ₩585.8mThe 2020 consensus revenue estimate decreased from ₩675.0m. Earning per share (EPS) estimate was also lowered from ₩1,915 to ₩1,792 for the same period. Net income is expected to grow by 24% next year compared to 40% growth forecast for the Chemicals industry in South Korea. The consensus price target increased from ₩23,250 to ₩24,250. Share price is up 8.5% to ₩24,900 over the past week.Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 20% share price gain to ₩25,900, the stock is trading at a trailing P/E ratio of 16x, up from the previous P/E ratio of 13.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 25%.Price Target Changed • Nov 10Price target raised to ₩24,250Up from ₩21,900, the current price target is an average from 4 analysts. The new target price is 6.9% below the current share price of ₩26,050. As of last close, the stock is up 16% over the past year.Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 17% share price gain to ₩27,150, the stock is trading at a trailing P/E ratio of 16.7x, up from the previous P/E ratio of 14.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 34%.Is New 90 Day High Low • Nov 09New 90-day high: ₩27,150The company is up 66% from its price of ₩16,400 on 11 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩13,972 per share.이익 및 매출 성장 예측KOSE:A069260 - 애널리스트 향후 추정치 및 과거 재무 데이터 (KRW Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20281,321,95061,85099,400114,700212/31/20271,352,80074,45096,200122,600212/31/20261,295,30065,00090,60098,00013/31/20261,153,31859,39786,65998,377N/A12/31/20251,127,69159,90790,436102,429N/A9/30/20251,163,14469,09198,157111,482N/A6/30/20251,166,17358,61642,81264,654N/A3/31/20251,156,69261,67641,57567,083N/A12/31/20241,188,23977,65545,51979,257N/A9/30/20241,097,50689,85032,99176,880N/A6/30/20241,039,724101,15366,498142,601N/A3/31/20241,038,946120,044103,206189,275N/A12/31/20231,052,689134,775107,314221,566N/A9/30/20231,133,033118,93557,228189,106N/A6/30/20231,247,813118,7056,286127,047N/A3/31/20231,256,18699,989-34,73388,609N/A12/31/20221,235,83881,708-47,80144,370N/A3/31/2022979,14679,55567,37294,918N/A12/31/2021861,20575,66061,58383,804N/A9/30/2021771,25465,53956,66375,452N/A6/30/2021678,79663,44158,72577,161N/A3/31/2021590,03648,83564,08879,043N/A12/31/2020593,51149,58768,79990,694N/A9/30/2020604,61448,18360,96788,529N/A6/30/2020645,17262,27256,46592,223N/A3/31/2020672,01072,93551,08089,032N/A12/31/2019659,77370,358N/A107,283N/A9/30/2019665,67375,749N/A95,462N/A6/30/2019689,46580,125N/A110,203N/A3/31/2019738,85995,584N/A121,828N/A12/31/2018762,875104,498N/A116,631N/A9/30/2018757,233115,653N/A139,669N/A6/30/2018735,245112,967N/A164,852N/A3/31/2018719,506114,392N/A166,578N/A12/31/2017715,765114,391N/A156,381N/A9/30/2017702,262104,315N/A169,310N/A6/30/2017676,65188,226N/A124,629N/A3/31/2017648,22668,733N/A118,796N/A12/31/2016598,23243,116N/A115,486N/A9/30/2016601,98541,586N/A94,651N/A6/30/2016596,07734,050N/A78,606N/A3/31/2016576,18827,767N/A87,100N/A12/31/2015600,42636,632N/A66,496N/A9/30/2015647,82438,865N/A97,113N/A6/30/2015682,09642,107N/A119,825N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: A069260 의 연간 예상 수익 증가율(2.6%)이 saving rate(3.1%) 미만입니다.수익 vs 시장: A069260 의 연간 수익(2.6%)이 KR 시장(33.4%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: A069260 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: A069260 의 수익(연간 4.8%)이 KR 시장(연간 16.4%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: A069260 의 수익(연간 4.8%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: A069260의 자본 수익률은 3년 후 7.5%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/17 08:31종가2026/06/17 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스TKG Huchems Co., Ltd.는 15명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jae Sung YoonDaishin Securities Co. Ltd.Ji Hwan YangDaishin Securities Co. Ltd.Hee Cheol LeeDAOL Investment & Securities Co., Ltd.12명의 분석가 더 보기
Price Target Changed • Feb 23Price target decreased by 8.8% to ₩22,500Down from ₩24,667, the current price target is an average from 2 analysts. New target price is 11% above last closing price of ₩20,350. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₩1,748 for next year compared to ₩2,024 last year.
Price Target Changed • Mar 27Price target decreased by 8.4% to ₩24,500Down from ₩26,750, the current price target is an average from 2 analysts. New target price is 54% above last closing price of ₩15,950. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩2,115 for next year compared to ₩2,024 last year.
Price Target Changed • Jan 01Price target decreased by 8.5% to ₩26,750Down from ₩29,250, the current price target is an average from 4 analysts. New target price is 57% above last closing price of ₩17,050. Stock is down 17% over the past year. The company is forecast to post earnings per share of ₩2,062 for next year compared to ₩3,512 last year.
Major Estimate Revision • Aug 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.17b to ₩1.23b. EPS estimate fell from ₩2,704 to ₩2,361 per share. Net income forecast to grow 4.9% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩28,750 unchanged from last update. Share price was steady at ₩18,940 over the past week.
Major Estimate Revision • Jul 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.15b to ₩1.17b. EPS estimate fell from ₩2,716 to ₩2,356 per share. Net income forecast to shrink 19% next year vs 67% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩28,750. Share price was steady at ₩19,130 over the past week.
Major Estimate Revision • Mar 06Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩1.27b to ₩1.20b. EPS estimate also fell from ₩3,173 per share to ₩2,778 per share. Net income forecast to grow 32% next year vs 52% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩31,000 unchanged from last update. Share price was steady at ₩19,760 over the past week.
공시 • Apr 24TKG Huchems Co., Ltd. announced that it has received KRW 50 billion in funding from J&Alpha Co., LtdOn April 23, 2026, TKG Huchems Co., Ltd. has closed the transaction.
공시 • Apr 10TKG Huchems Co., Ltd. announced that it expects to receive KRW 50 billion in funding from J&Alpha Co., LtdTKG Huchems Co., Ltd. announced a private placement of series 4 unsecured privately placed exchangeable bond with bearer interest for gross proceeds of KRW 50,000,000,000 on April 8, 2026. The transaction will include participation from a new investor, J&Alpha Co., Ltd. for KRW 50,000,000,000. The bond has a maturity interest rate of 1% and will mature on April 23, 2031. The bonds are fully convertible into 2,819,283 common shares of the company at a conversion price of KRW 17,735 per share. The bonds can be converted between April 24, 2027 and March 23, 2031. The transaction is expected to close on April 23, 2026. The subscription date is April 23, 2026. The transaction has been approved by the board of directors of the company on April 8, 2026.
Reported Earnings • Mar 24Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: ₩1,561 (down from ₩2,024 in FY 2024). Revenue: ₩1.13t (down 5.1% from FY 2024). Net income: ₩59.9b (down 23% from FY 2024). Profit margin: 5.3% (down from 6.5% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.8%. Earnings per share (EPS) also missed analyst estimates by 11%. Revenue is forecast to grow 9.3% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩16,900, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 14x in the Chemicals industry in South Korea. Negligible returns to shareholders over past three years.
공시 • Feb 27TKG Huchems Co., Ltd., Annual General Meeting, Mar 26, 2026TKG Huchems Co., Ltd., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 173, toegye-ro, jung-gu, seoul South Korea
Price Target Changed • Feb 23Price target decreased by 8.8% to ₩22,500Down from ₩24,667, the current price target is an average from 2 analysts. New target price is 11% above last closing price of ₩20,350. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₩1,748 for next year compared to ₩2,024 last year.
Upcoming Dividend • Feb 19Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 26 February 2026. Payment date: 24 April 2026. Payout ratio is a comfortable 56% and this is well supported by cash flows. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.4%). Higher than average of industry peers (1.2%).
분석 기사 • Nov 24TKG Huchems' (KRX:069260) Sluggish Earnings Might Be Just The Beginning Of Its ProblemsA lackluster earnings announcement from TKG Huchems Co., Ltd. ( KRX:069260 ) last week didn't sink the stock price. Our...
New Risk • Nov 24New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
분석 기사 • May 24TKG Huchems' (KRX:069260) Sluggish Earnings Might Be Just The Beginning Of Its ProblemsThe subdued market reaction suggests that TKG Huchems Co., Ltd.'s ( KRX:069260 ) recent earnings didn't contain any...
Price Target Changed • Mar 27Price target decreased by 8.4% to ₩24,500Down from ₩26,750, the current price target is an average from 2 analysts. New target price is 54% above last closing price of ₩15,950. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩2,115 for next year compared to ₩2,024 last year.
New Risk • Mar 19New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.5% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.5% net profit margin).
Reported Earnings • Mar 19Full year 2024 earnings: EPS in line with analyst expectations despite revenue beatFull year 2024 results: EPS: ₩2,024 (down from ₩3,512 in FY 2023). Revenue: ₩1.19t (up 13% from FY 2023). Net income: ₩77.7b (down 42% from FY 2023). Profit margin: 6.5% (down from 13% in FY 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
공시 • Feb 21TKG Huchems Co., Ltd., Annual General Meeting, Mar 21, 2025TKG Huchems Co., Ltd., Annual General Meeting, Mar 21, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 173, toegye-ro, jung-gu, seoul South Korea
Price Target Changed • Jan 01Price target decreased by 8.5% to ₩26,750Down from ₩29,250, the current price target is an average from 4 analysts. New target price is 57% above last closing price of ₩17,050. Stock is down 17% over the past year. The company is forecast to post earnings per share of ₩2,062 for next year compared to ₩3,512 last year.
Upcoming Dividend • Dec 20Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 21 April 2025. Payout ratio is a comfortable 43% but the company is paying out more than the cash it is generating. Trailing yield: 5.4%. Within top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%).
분석 기사 • Nov 22TKG Huchems' (KRX:069260) Shareholders Have More To Worry About Than Only Soft EarningsA lackluster earnings announcement from TKG Huchems Co., Ltd. ( KRX:069260 ) last week didn't sink the stock price. We...
공시 • Aug 28TKG Huchems Co., Ltd. (KOSE:A069260) agreed to acquire 50% stake in JL Chem Co., Ltd. for KRW 60.3 billion.TKG Huchems Co., Ltd. (KOSE:A069260) agreed to acquire 50% stake in JL Chem Co., Ltd. for KRW 60.3 billion on August 27, 2024. A cash consideration of KRW 60.33 billion will be paid by TKG Huchems for 502,721 shares. The expected completion of the transaction is August 28, 2024.
Major Estimate Revision • Aug 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.17b to ₩1.23b. EPS estimate fell from ₩2,704 to ₩2,361 per share. Net income forecast to grow 4.9% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩28,750 unchanged from last update. Share price was steady at ₩18,940 over the past week.
Major Estimate Revision • Jul 23Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.15b to ₩1.17b. EPS estimate fell from ₩2,716 to ₩2,356 per share. Net income forecast to shrink 19% next year vs 67% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩28,750. Share price was steady at ₩19,130 over the past week.
New Risk • Jul 22New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 2.8% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.8% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
분석 기사 • Mar 21TKG Huchems' (KRX:069260) Solid Earnings May Rest On Weak FoundationsThe recent earnings posted by TKG Huchems Co., Ltd. ( KRX:069260 ) were solid, but the stock didn't move as much as we...
Major Estimate Revision • Mar 06Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩1.27b to ₩1.20b. EPS estimate also fell from ₩3,173 per share to ₩2,778 per share. Net income forecast to grow 32% next year vs 52% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩31,000 unchanged from last update. Share price was steady at ₩19,760 over the past week.
공시 • Feb 22TKG Huchems Co., Ltd., Annual General Meeting, Mar 22, 2024TKG Huchems Co., Ltd., Annual General Meeting, Mar 22, 2024, at 09:01 Korea Standard Time. Location: Namsan Square 19F, Toegyero 173, Junggu Seoul South Korea Agenda: To report Business Report, to consider audit Report; to consider Internal Accounting Control System Report; to consider approval of Financial Statements for the 22nd Term; to consider election of directors; to consider election of Executive Directors; to consider approval of ceiling amount for the remuneration onto Directors; and to consider approval of ceiling amount for the remuneration onto Auditor.
Upcoming Dividend • Dec 20Upcoming dividend of ₩1,000 per share at 4.4% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 22 April 2024. Trailing yield: 4.4%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).
New Risk • Oct 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Major Estimate Revision • May 25Consensus revenue estimates decrease by 10%, EPS upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from ₩1.04b to ₩939.0m. EPS estimate increased from ₩2,449 to ₩2,939 per share. Net income forecast to grow 29% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target up from ₩29,000 to ₩31,000. Share price was steady at ₩23,350 over the past week.
Valuation Update With 7 Day Price Move • Mar 31Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩21,800, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 68% over the past three years.
Major Estimate Revision • Jan 18Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₩1.21b to ₩1.23b. EPS estimate fell from ₩2,643 to ₩2,373 per share. Net income forecast to grow 25% next year vs 25% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩32,500 to ₩29,500. Share price was steady at ₩19,600 over the past week.
Upcoming Dividend • Dec 21Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. Payout ratio is a comfortable 48% and this is well supported by cash flows. Trailing yield: 4.7%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩23,400, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 24% over the past three years.
Major Estimate Revision • Jul 15Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ₩3,370 to ₩2,842 per share. Revenue forecast steady at ₩1.30b. Net income forecast to grow 46% next year vs 11% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩32,500 unchanged from last update. Share price fell 8.0% to ₩18,300 over the past week.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Upcoming Dividend • Dec 22Upcoming dividend of ₩1,000 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 4.3%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%).
Price Target Changed • Dec 10Price target increased to ₩30,750Up from ₩27,750, the current price target is an average from 4 analysts. New target price is 29% above last closing price of ₩23,750. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of ₩2,281 for next year compared to ₩1,292 last year.
Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩27,450, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩31,191 per share.
Major Estimate Revision • May 14Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 EPS estimate increased from ₩2,209 to ₩2,466. Revenue forecast steady at ₩772.0m. Net income forecast to grow 92% next year vs 87% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩27,750 unchanged from last update. Share price was steady at ₩21,900 over the past week.
분석 기사 • May 05Is Huchems Fine Chemical (KRX:069260) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Apr 01Investors Will Want Huchems Fine Chemical's (KRX:069260) Growth In ROCE To PersistIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Reported Earnings • Mar 20Full year 2020 earnings released: EPS ₩1,292 (vs ₩1,812 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩593.5b (down 10.0% from FY 2019). Net income: ₩49.6b (down 30% from FY 2019). Profit margin: 8.4% (down from 11% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
분석 기사 • Mar 17Is Huchems Fine Chemical Corporation (KRX:069260) Popular Amongst Institutions?The big shareholder groups in Huchems Fine Chemical Corporation ( KRX:069260 ) have power over the company...
Is New 90 Day High Low • Mar 10New 90-day low: ₩21,300The company is down 11% from its price of ₩23,800 on 10 December 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,740 per share.
분석 기사 • Mar 02Are Huchems Fine Chemical Corporation's (KRX:069260) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?It is hard to get excited after looking at Huchems Fine Chemical's (KRX:069260) recent performance, when its stock has...
공시 • Feb 27Huchems Fine Chemical Corporation, Annual General Meeting, Mar 26, 2021Huchems Fine Chemical Corporation, Annual General Meeting, Mar 26, 2021, at 09:00 Korea Standard Time.
분석 기사 • Feb 15Here's What You Should Know About Huchems Fine Chemical Corporation's (KRX:069260) 4.2% Dividend YieldDividend paying stocks like Huchems Fine Chemical Corporation ( KRX:069260 ) tend to be popular with investors, and for...
Major Estimate Revision • Feb 12Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate was lowered from ₩1,764 to ₩1,543. No change was made to the revenue estimate which at the last update was ₩590.1m. Net income is expected to grow by 72% next year compared to 60% growth forecast for the Chemicals industry in South Korea. The consensus price target of ₩30,000 was unchanged from the last update. Share price stayed mostly flat at ₩22,550 over the past week.
Price Target Changed • Feb 03Price target raised to ₩30,000Up from ₩24,250, the current price target is an average from 2 analysts. The new target price is 28% above the current share price of ₩23,450. As of last close, the stock is up 22% over the past year.
분석 기사 • Feb 01Huchems Fine Chemical (KRX:069260) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Is New 90 Day High Low • Jan 29New 90-day low: ₩21,400The company is down 7.0% from its price of ₩22,900 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 39% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,786 per share.
분석 기사 • Jan 19Huchems Fine Chemical (KRX:069260) Has Compensated Shareholders With A Respectable 89% Return On Their InvestmentIf you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to...
분석 기사 • Jan 06Does Huchems Fine Chemical's (KRX:069260) Statutory Profit Adequately Reflect Its Underlying Profit?As a general rule, we think profitable companies are less risky than companies that lose money. That said, the current...
Price Target Changed • Dec 30Price target raised to ₩25,000Up from ₩23,250, the current price target is an average from 3 analysts. The new target price is close to the current share price of ₩25,650. As of last close, the stock is up 21% over the past year.
분석 기사 • Dec 24Huchems Fine Chemical Corporation (KRX:069260) Goes Ex-Dividend SoonHuchems Fine Chemical Corporation ( KRX:069260 ) stock is about to trade ex-dividend in 3 days. You can purchase shares...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩1,000 Per ShareWill be paid on the 24th of April to those who are registered shareholders by the 29th of December. The trailing yield of 4.1% is in the top quartile of South Korean dividend payers (2.6%), and it is higher than industry peers (0.9%).
분석 기사 • Dec 13What Is The Ownership Structure Like For Huchems Fine Chemical Corporation (KRX:069260)?A look at the shareholders of Huchems Fine Chemical Corporation ( KRX:069260 ) can tell us which group is most...
분석 기사 • Nov 29Is Huchems Fine Chemical Corporation's (KRX:069260) Recent Stock Performance Influenced By Its Fundamentals In Any Way?Huchems Fine Chemical's (KRX:069260) stock is up by a considerable 36% over the past three months. Given that stock...
Major Estimate Revision • Nov 12Analysts lower revenue estimates to ₩585.8mThe 2020 consensus revenue estimate decreased from ₩675.0m. Earning per share (EPS) estimate was also lowered from ₩1,915 to ₩1,792 for the same period. Net income is expected to grow by 24% next year compared to 40% growth forecast for the Chemicals industry in South Korea. The consensus price target increased from ₩23,250 to ₩24,250. Share price is up 8.5% to ₩24,900 over the past week.
Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 20% share price gain to ₩25,900, the stock is trading at a trailing P/E ratio of 16x, up from the previous P/E ratio of 13.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 25%.
Price Target Changed • Nov 10Price target raised to ₩24,250Up from ₩21,900, the current price target is an average from 4 analysts. The new target price is 6.9% below the current share price of ₩26,050. As of last close, the stock is up 16% over the past year.
Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 17% share price gain to ₩27,150, the stock is trading at a trailing P/E ratio of 16.7x, up from the previous P/E ratio of 14.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 34%.
Is New 90 Day High Low • Nov 09New 90-day high: ₩27,150The company is up 66% from its price of ₩16,400 on 11 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩13,972 per share.